Evidence map›Paper›PMID 31684762›Full record

ArticleCell transplantation2019

Non-Invasive Cell Tracking with Brighter and Red-Transferred Luciferase for Potential Application in Stem Cell Therapy.

Lei Dou, Ethan L Matz, Xin Gu, Fangpeng Shu, Jennifer Paxton, Jinlin Song, James Yoo, Anthony Atala, John Jackson, Yuanyuan Zhang

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Lei DouStomatological Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0002-7363-9724
Ethan L MatzWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Xin GuWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Fangpeng ShuWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Jennifer PaxtonWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Jinlin SongStomatological Hospital of Chongqing Medical University, Chongqing, China.
James YooWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Anthony AtalaWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
John JacksonWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Yuanyuan ZhangWake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
Forest Institute · USStomatological Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the safety of a novel cell-labeling technology with mKATE and

Indexed as

Cell MovementCell ProliferationCell TrackingLuciferasesMesenchymal Stem Cell TransplantationAnimalsFemaleHeterograftsHumansMesenchymal Stem CellsPlacentaPregnancyRatsLuciferasescell therapydual labelingluciferasestem celltracking

Identifiers

PMID31684762
PMCPMC6923553
OpenAlexW2985087126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.